Pfizer buys blood firm for $5.4B
Pfizer, the pharmaceutical giant that became a cash-generating machine thanks to its coronavirus vaccine, is bringing Global Blood Therapeutics into the fold under a $5.4 billion a…
Pfizer, the pharmaceutical giant that became a cash-generating machine thanks to its coronavirus vaccine, is bringing Global Blood Therapeutics into the fold under a $5.4 billion a…